OBLIQUE THERAPEUTICS
LIVE

Serial Number

88178276

Owner

Oblique Therapeutics AB

Attorney

James F. Keenan, Jr.

First Use Date

Dec 31, 2015

Filing Date

Nov 1, 2018

Add to watchlist:

No watchlists yet
View on USPTO

OBLIQUE THERAPEUTICS Trademark

Serial Number: 88178276 • Registration: 6335551

OBLIQUE THERAPEUTICS is a trademark filed by Oblique Therapeutics AB on November 1, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Oblique Therapeutics AB (4 trademarks)

Arvid Wallgrens Backe 20
413 46 Göteborg 41346 , SE

Entity Type: 99

Trademark Details

Filing Date

November 1, 2018

Registration Date

April 27, 2021

First Use Anywhere

December 31, 2015

First Use in Commerce

December 31, 2015

Published for Opposition

July 9, 2019

Goods & Services

Research and development regarding pharmaceuticals and pharmaceutical preparations; Research and development for the pharmaceutical industry; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting early evaluations in the field of new pharmaceuticals; Medical research in the field of cancer; Pharmaceutical research; Biological research; Bacteriological research; Scientific research for medical purposes in the area of cancerous diseases; Cell separation technology research services; Medical research laboratory services; Laboratory research services relating to the production of monoclonal antibodies; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Scientific research and development; Science and technology research services in the field of medicine; Technological analysis services in the field of medical research

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 27, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 27, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 23, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 20, 2021 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 17, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 16, 2021 SUPC
SOU EXTENSION 3 GRANTED
Mar 16, 2021 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 16, 2021 AITU
USE AMENDMENT FILED
Mar 2, 2021 IUAF
SOU EXTENSION 3 FILED
Mar 2, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 2, 2021 EEXT
TEAS STATEMENT OF USE RECEIVED
Mar 2, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2020 EXRA
SOU EXTENSION 2 GRANTED
Aug 12, 2020 EX2G
SOU EXTENSION 2 FILED
Aug 12, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 12, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 29, 2020 EXRA
SOU EXTENSION 1 GRANTED
Feb 20, 2020 EX1G
SOU EXTENSION 1 FILED
Feb 20, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 20, 2020 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 20, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2020 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2019 NONP
ASSIGNED TO LIE
Jun 3, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 7, 2019 GNRN
NON-FINAL ACTION E-MAILED
Feb 7, 2019 GNRT
NON-FINAL ACTION WRITTEN
Feb 7, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2018 NWOS
NEW APPLICATION ENTERED
Nov 5, 2018 NWAP